期刊文献+

阿立哌唑与利培酮治疗孤独症并冲动行为障碍儿童的治疗效果对比 被引量:5

下载PDF
导出
摘要 目的探讨阿立哌唑与利培酮治疗孤独症并冲动行为障碍儿童的治疗效果对比。方法选择2017年2月-2019年2月我院收治的孤独症并冲动行为障碍儿童84例,按照随机数字表法分为对照组和观察组,各42例。对照组给予利培酮治疗,观察组给予阿立哌唑治疗,治疗后1个月评估患儿效果,比较两组的总有效率以及用药安全性。结果观察组临床有效率(80.96%)高于对照组(69.05%)(P<0.05);观察组不良反应发生率为26.19%(11/42),低于对照组的47.62%(20/42)(P<0.05)。结论相较于利培酮,阿立哌唑治疗孤独症并冲动行为障碍儿童有助于改善患儿临床效果,减少不良反应的发生,提高用药的安全性,值得推广应用。
出处 《解放军预防医学杂志》 CAS 2019年第10期40-41,共2页 Journal of Preventive Medicine of Chinese People's Liberation Army
基金 2018重庆市科委社会民生项目(No.cstc2018jscx-msyb X0189)
  • 相关文献

参考文献9

二级参考文献87

  • 1叶兴荣,夏旭兰.阿立哌唑与利培酮治疗首发精神分裂症的对照研究[J].西南国防医药,2005,15(6):616-618. 被引量:6
  • 2Kristensen D, Hageman I, Bauer J, et al. Antipsychotic polypharmacy in a treatment-refractory schizophrenia population receiving adjunctive treatment with electroconvulsive therapy [J]. J ECT,2013, 29(4): 271-276.
  • 3Sasaki T, Hashimoto T, Niitsu T, et al. Treatment of refractory catatonic schizophrenia with low dose aripiprazole [J]. Ann Gen Psychiatry, 2012, 11(1): 12-13.
  • 4Melnik T, Soares BG, Puga ME, et al. Efficacy and safety of atypical antipsychotic drugs (quetiapine,risperidone,aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia:overview of systematic reviews [J]. Sao Panlo Med J, 2010, 128(3): 141-166.
  • 5Asenjo Lobos C, Komossa K, et al. Clozapine versus other atypical antipsychotics for schizophrenia [J]. Cochrane Database Syst Rev, 2010, 10(11): 6633-6634.
  • 6Grover S, Dutt A, Chakrabarty K, et al. Treatment resistant non-catatonic mutism in schizophrenia responding to a combination of continuation electroconvulsive therapy and neuroleptics [J]. Ind Psychiatry J, 2012, 21(1): 69-71.
  • 7Schimmelmann BG, Schmidt S J, Carbon M, et al. Treatment of adolescents with early-onset schizophrenia spectrum disorders:in search of a rational, evidence-informed approach [J]. Curt Opin Psychiatry, 2013, 26(2): 219-230.
  • 8Chang TS, Tsai CK, Liang CS, et al. Clozapine use in refractory schizophrenia comorbid with acute myeloid leukemia [J]. Psychosomatics, 2015, 56(3): 302-305.
  • 9Bumb JM, Enning F, Leweke FM, et al. Drug repurposing and emerging adjunctive treatments for schizophrenia [J]. Expert Opin Pharmacother, 2015, 16(7): 1049-1067.
  • 10Nakajima S, Takeuchi H, Plitman E, et al. Neuroimaging findings in treatment-resistant schizophrenia:A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia [J]. Schizophr Res, 2015, 164(1): 164-175.

同被引文献69

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部